ESPN Golf: Trey Mullinax Handed Six-Month PGA Tour Ban for Anti-Doping Breach

What Happened

The PGA Tour announced on July 29, 2026, that Trey Mullinax has been handed a six-month suspension for violating its anti-doping policy. He tested positive for a substance prohibited by the World Anti-Doping Agency (WADA).

In a statement, Mullinax explained that the substance came from a medication he used to treat a condition diagnosed during his college years — and that he had not sought the required approval before taking it. "My lack of knowledge is not an excuse," he said, firmly denying any intent to gain a competitive advantage.

Context Within Tour History

This marks the ninth suspension since the PGA Tour began drug testing in 2008, and the first since Byeong Hun An in October 2023. An's case involved an over-the-counter cough syrup purchased in South Korea that contained a banned substance — another example of an inadvertent, non-performance-enhancing violation.

Where Mullinax Stands

Mullinax finished 150th in the FedEx Cup last season and held conditional status for 2026. He appeared in just three events this spring, with his final start coming at the Zurich Classic of New Orleans on April 27. He is eligible to return on January 16, 2027 — one week before the new season officially begins.

Strokeslab Take

The real story here isn't performance enhancement — it's the administrative burden placed on players to pre-clear every medication. As treatment-related violations continue to surface, the Tour may need to invest more in proactive player education around WADA compliance.